Rabson–Mendenhall Syndrome in a brother-sister pair in Kuwait: Diagnosis and 5 year follow up

Published:August 22, 2020DOI:https://doi.org/10.1016/j.pcd.2020.07.012


      • First report of Rabson–Mendenhall Syndrome from Kuwait.
      • Raises awareness of rare forms of diabetes among healthcare professionals.
      • Highlights the importance of access to genetic testing for accurate diagnosis.



      To report on Rabson–Mendenhall Syndrome (RMS) diagnosed in Kuwait.


      A toddler (18 months old) was referred with high plasma insulin and dysmorphic features suggestive of RMS including coarse facial features with globular nose, full lips and furrowed tongue. His skin was hyperkeratotic with hypertrichosis. His sister (aged 13.5 years) was diagnosed with diabetes at 9 years of age and treated with metformin and insulin. She presented with similar dysmorphic features, extensive acanthosis nigricans, dental abnormalities and bilateral nephrocalcinosis. The children were born to non-consanguineous parents. Blood samples were sent for genetic testing in a reference laboratory.


      Both children were found to be homozygous for the p.Arg141Trp missense variant (p.Arg114Trp if numbered according to pro-receptor sequence) in the alpha subunit of the insulin receptor.


      These cases demonstrate the importance of raising awareness among healthcare professionals to ensure rapid referral of patients with characteristic physical features of RMS and severe insulin resistance for genetic testing. Unfortunately, treatment of RMS patients remains a challenge with poor prognosis and short life expectancy usually caused by diabetes-related complications. Genetic testing confirms the diagnosis and allows informed genetic counseling of parents considering future pregnancies.


      To read this article in full you will need to make a payment


      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Carrasco de la Fuente M.
        • Barrio Castellanos R.
        • de la Calle Blasco H.
        Long survival in Rabson–Mendenhall syndrome. Letter to the editor.
        Diabetes Res. Clin. Pract. 2010; 89: e17-e18
        • Longo N.
        • Wang Y.
        • Marzia Pasquali M.
        Progressive decline in insulin levels in Rabson Mendenhall Syndrome.
        J. Clin. Endocrinol. Metab. 1999; 84: 2623-2629
        • Chong Y.H.
        • Taylor B.J.
        • Wheeler B.J.
        Renal manifestations of severe Rabson–Mendenhall syndrome: a case report.
        J. Diabetes Metab. Disord. 2013; 12: 7
        • Simpkin A.
        • Cochran E.
        • Cameron F.
        • et al.
        Insulin receptor and the kidney: nephrocalcinosis in patients with recessive INSR mutations.
        Nephron Physiol. 2014; 128: 55-61
        • Rabson S.
        • Mendenhall E.
        Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus: report of 3 cases.
        Am. J. Clin. Pathol. 1956; 26: 283-290
        • Bathi R.J.
        • Parveen S.
        • Mutalik S.
        • Rao R.
        Rabson–Mendenhall syndrome: two case reports and a brief review of the literature.
        Odontology. 2010; 98: 89-96
        • Atray A.
        • Jahnavi S.
        • Thai K.
        • et al.
        Rabson Mendenhall Syndrome: a case report.
        J. Diabetology. 2013; 2: 4
        • Alaei M.R.
        • Mirjavadi S.A.
        • Shiari R.
        Rabson–Mendenhall Syndrome: a case eport.
        Iran J. Child Neurology. 2010; 4: 49-52
        • Moreira R.O.
        • Zagury R.L.
        • Nascimento T.S.
        • Zagury L.
        Research letter: multidrug therapy in a patient with Rabson–Mendenhall syndrome.
        Diabetologia. 2010; 53: 2454-2455
        • Sinnarajah K.
        • Dayasiri M.B.
        • Dissanayake N.D.
        • et al.
        Rabson Mendenhall Syndrome caused by a novel missense mutation.
        Int. J. Pediatr. Endocrin. 2016; 2016: 21
        • Tuhan H.
        • Ceylaner S.
        • Nalbantoğlu Ö.
        • et al.
        A mutation in INSR in a child presenting with severe acanthosis nigricans.
        J. Clin. Res. Pediatr. Endocrinol. 2017; 9: 371-374
        • Bastaki F.
        • Nair P.
        • Mohamed M.
        • et al.
        Identification of a novel homozygous INSR variant in a patient with Rabson–Mendenhall Syndrome from the United Arab Emirates.
        Horm. Res. Paediatr. 2017; 87: 64-68https://doi.org/10.1159/000447090
        • World Health Organization
        Growth Reference 5–19 Years.
        • Hattersley A.T.
        • Greeley S.A.W.
        • Polak M.
        • et al.
        ISPAD clinical practice consensus guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents.
        Pediatr. Diabetes. 2018; 19: 47-63
        • Musso C.
        • Cochran E.
        • Moran S.A.
        • et al.
        Clinical course of genetic diseases of the insulin receptor (type A and Rabson–Mendenhall syndromes): a 30-year prospective.
        Medicine. 2004; 83: 209-222
        • Regan F.M.
        • Williams R.M.
        • McDonald A.
        • Margot Umpleby A.
        • et al.
        Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance.
        J. Clin. Endocrinol. Metab. 2010; 95: 2113-2122
        • Carmody D.
        • Ladsaria S.S.
        • Buikema R.K.
        • et al.
        Successful rhIGF1 treatment for over 5 years in a patient with severe insulin resistance due to homozygous insulin receptor mutation.
        Diabet. Med. 2016; 33: e8-e12